4.7 Review

The fickle CHO: a review of the causes, implications, and potential alleviation of the CHO cell line instability problem

期刊

CURRENT OPINION IN BIOTECHNOLOGY
卷 60, 期 -, 页码 128-137

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.copbio.2019.01.011

关键词

-

资金

  1. National Science Foundation [1624698, 1736123]
  2. Div Of Industrial Innovation & Partnersh
  3. Directorate For Engineering [1624698] Funding Source: National Science Foundation
  4. Office of Integrative Activities
  5. Office Of The Director [1736123] Funding Source: National Science Foundation

向作者/读者索取更多资源

Chinese hamster ovary (CHO) cell-based bioproduction of recombinant proteins can now routinely achieve >5 g/L titers in fed-batches. This progress is partly due to the rapid adaptability of CHO cells to various genetic manipulations and changing process conditions. An inherently plastic genome allows for this adaptability; however, it also gives CHO cells the propensity for genomic rearrangements. In combination with the genomic and metabolic demand of high producer cells, CHO cell plasticity manifests itself in the bioproduction process as cell line instability, by way of a decline in productivity and product quality. In this review, we provide a definition for titer and quality stability and discuss the main causes of the CHO instability phenomenon and advances in clone selection and genetic manipulations. We also discuss advances in systems biology efforts that can provide new strategies for early prediction of CHO cell instability, which will help to identify multi-gram per liter titer cell lines that can maintain production stability and reproducible product quality over extended culture durations.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biotechnology & Applied Microbiology

Restoration of DNA repair mitigates genome instability and increases productivity of Chinese hamster ovary cells

Philipp N. Spahn, Xiaolin Zhang, Qing Hu, Huiming Lu, Nathaniel K. Hamaker, Hooman Hefzi, Shangzhong Li, Chih-Chung Kuo, Yingxiang Huang, Jamie C. Lee, Anthony J. Davis, Peter Ly, Kelvin H. Lee, Nathan E. Lewis

Summary: This study identified deleterious single-nucleotide variants in DNA repair genes in CHO cells, which contribute to productivity loss and genome instability. Correcting these DNA repair genes improves genome stability and protein expression in CHO cells.

BIOTECHNOLOGY AND BIOENGINEERING (2022)

Article Biotechnology & Applied Microbiology

Characterization of Monoclonal Antibody Glycan Heterogeneity Using Hydrophilic Interaction Liquid Chromatography-Mass Spectrometry

Sumit K. Singh, Kelvin H. Lee

Summary: Glycosylation is a critical quality attribute of monoclonal antibody therapeutics. Hydrophilic interaction liquid chromatography-mass spectrometry (HILIC-MS) is a valuable technology for glycosylation characterization. Traditional glycan analysis based on glucose units (GU) and accurate mass (AM) is not suitable for complex samples or high-throughput applications. This study presents a two-step strategy for targeted glycan analysis and its application in different scenarios.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)

Article Biotechnology & Applied Microbiology

Comprehensive assessment of host cell protein expression after extended culture and bioreactor production of CHO cell lines

Nathaniel K. Hamaker, Lie Min, Kelvin H. Lee

Summary: The biomanufacturing industry is moving towards continuous processes, which may pose challenges due to fluctuations in host cell protein (HCP) levels. A study on Chinese hamster ovary (CHO) cells showed that HCP expression changes over time, but not as dramatically as originally expected.

BIOTECHNOLOGY AND BIOENGINEERING (2022)

Review Chemistry, Applied

Biopharmaceutical Manufacturing: Historical Perspectives and Future Directions

Alana C. Szkodny, Kelvin H. Lee

Summary: This review highlights the key milestones in the production of biopharmaceuticals and emphasizes the maturity of the technologies used and the importance of understanding the interaction between product quality and processing conditions.

ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING (2022)

Article Biotechnology & Applied Microbiology

Biomanufacturing readiness levels-A shared vocabulary for biopharmaceutical technology development and commercialization

Sandeep B. Kedia, Jeffrey C. Baker, Ruben G. Carbonell, Kelvin H. Lee, Christopher J. Roberts, John Erickson, John E. Schiel, Kelley Rogers, Gene Schaefer, Stefanie Pluschkell

Summary: The Manufacturing Readiness Levels (MRLs) are well-established tools for describing technology maturity, and the Biomanufacturing Readiness Levels (BRLs) provide a specific viewpoint for the biomanufacturing industry.

BIOTECHNOLOGY AND BIOENGINEERING (2022)

Article Biotechnology & Applied Microbiology

Characterization and implications of host-cell protein aggregates in biopharmaceutical processing

Young Hoon Oh, Matthew L. Becker, Kerri M. Mendola, Leila H. Choe, Lie Min, Kelvin H. H. Lee, Yinges Yigzaw, Alexander Seay, Jerome Bill, Xuanwen Li, David J. Roush, Steven M. Cramer, Stefano Menegatti, Abraham M. Lenhoff

Summary: In the production of biopharmaceuticals, the presence of residual host-cell proteins (HCPs) is a critical quality concern. Measurements on seven monoclonal antibody (mAb) processes revealed that HCP aggregates, not necessarily derived from chromatin, are important factors in the persistence of HCPs. These aggregates can also interfere with accurate detection of HCPs using proteomics methods. The study also highlights the difficulty in removing certain HCPs due to their functional complementarity to the biopharmaceutical product.

BIOTECHNOLOGY AND BIOENGINEERING (2023)

Article Biotechnology & Applied Microbiology

Generation of reference cell lines, media, and a process platform for CHO cell biomanufacturing

Lauren T. Cordova, Hussain Dahodwala, Kathryn S. Elliott, Jongyoun Baik, Daniel C. Odenewelder, Douglas Nmagu, Bradley A. Skelton, Lisa Uy, Stephanie R. Klaubert, Benjamin F. Synoground, Dylan G. Chitwood, Venkata Gayatri Dhara, Harnish Mukesh Naik, Caitlin S. Morris, Seongkyu Yoon, Michael Betenbaugh, Jon Coffman, Frank Swartzwelder, Michael Gilmeister, Sarah W. Harcum, Kelvin H. Lee

Summary: Due to the limitations in cell, media, and feed diversity, as well as the limited public availability of industrially relevant CHO cells, the knowledge translation and research progress in the field have been hindered. To address this issue, AMBIC has acquired two CHO reference cell lines from different lineages and developed detailed technology transfer protocols and a chemically defined media formulation, aiming to provide a universal and industrially relevant CHO culture platform.

BIOTECHNOLOGY AND BIOENGINEERING (2023)

Article Biotechnology & Applied Microbiology

High-efficiency and multilocus targeted integration in CHO cells using CRISPR-mediated donor nicking and DNA repair inhibitors

Nathaniel. K. K. Hamaker, Kelvin. H. H. Lee

Summary: Efforts to improve CRISPR/Cas9 efficiency in targeted genomic modifications in mammalian cells led to the development of an all-in-one reporter system, including a new superfolder orange fluorescent protein (sfOrange), to quantify gene disruption, site-specific integration (SSI), and random integration (RI). Different donor plasmid formats and Cas9 nuclease variants were evaluated for accuracy and efficiency in Chinese hamster ovary cells. Double-cut and double-nick donor formats significantly improved targeting accuracy, and Cas9-mediated donor linearization increased RI events while donor nicking minimized RI without sacrificing SSI efficiency.

BIOTECHNOLOGY AND BIOENGINEERING (2023)

Review Biotechnology & Applied Microbiology

Driving adoption of new technologies in biopharmaceutical manufacturing

Gene Schaefer, John Balchunas, Timothy Charlebois, John Erickson, Roger Hart, Sandeep B. Kedia, Kelvin H. Lee

Summary: The challenge of introducing new technologies into established industries is not unique to biopharmaceuticals, but it is crucial for the long-term competitiveness and delivery of therapies, particularly for new treatment modalities such as cell and gene therapies. This review identifies barriers to technology adoption and proposes enablers and suggestions for synergy and connection between innovation in product discovery and manufacturing, and across supplier, discovery, manufacturing, and regulatory arms.

BIOTECHNOLOGY AND BIOENGINEERING (2023)

Article Biotechnology & Applied Microbiology

A compendium of stable hotspots in the CHO genome

William Hilliard, Kelvin H. Lee

Summary: The use of targeted integration for industrial CHO cell line development requires significant upfront effort to identify genomic loci capable of supporting high therapeutic protein production. To address this barrier, the Transgene Integrated in Parallel screening method was used to characterize transgene expression from thousands of stable hotspots in the CHO genome. Cell lines with integrations at retargeted hotspot candidates consistently exhibited higher transgene mRNA expression than a commercially viable hotspot. These findings provide valuable resources for targeted integration platform development in the CHO community.

BIOTECHNOLOGY AND BIOENGINEERING (2023)

Article Biotechnology & Applied Microbiology

Analytical characterization of host-cell-protein-rich aggregates in monoclonal antibody solutions

Chase E. Herman, Lie Min, Leila H. Choe, Ronald W. Maurer, Xuankuo Xu, Sanchayita Ghose, Kelvin H. H. Lee, Abraham M. Lenhoff

Summary: Recent research suggests that host-cell proteins (HCPs) and high molecular weight (HMW) species in monoclonal antibody downstream processing may be linked. Proteomic analysis reveals substantial overlap of HCP profiles between harvest cell culture fluid (HCCF) and protein A eluate, with HCPs conserved in aggregates that persist through the protein A capture step. These findings support previous hypotheses and highlight the importance of this persistence mechanism.

BIOTECHNOLOGY PROGRESS (2023)

Article Biotechnology & Applied Microbiology

Identification and characterization of CHO host-cell proteins in monoclonal antibody bioprocessing

Young Hoon Oh, Kerri M. Mendola, Leila H. Choe, Lie Min, Ashton R. Lavoie, Sobhana A. Sripada, Taufika Islam Williams, Kelvin H. Lee, Yinges Yigzaw, Alexander Seay, Jerome Bill, Xuanwen Li, David J. Roush, Steven M. Cramer, Stefano Menegatti, Abraham M. Lenhoff

Summary: This study investigates the characterization and persistence of host-cell proteins (HCPs) in downstream processing steps for monoclonal antibody (mAb) manufacturing. The results show variability in HCP identities during processing steps, but consistency in the most abundant HCPs across different processes. The abundance of HCPs is likely related to the reproducibility of quantification measurements, and certain groups of HCPs may hinder characterization. The study suggests that factors such as HCP abundance and mAb-HCP interactions contribute to the persistence of individual HCPs and the identification of common, persistent HCPs in mAb manufacturing.

BIOTECHNOLOGY AND BIOENGINEERING (2023)

Article Biotechnology & Applied Microbiology

Design space determination to optimize DNA complexation and full capsid formation in transient rAAV manufacturing

Qiang Fu, Yong Suk Lee, Erica A. Green, Yongdan Wang, So Young Park, Ashli Polanco, Kelvin H. Lee, Michael Betenbaugh, David McNally, Seongkyu Yoon

Summary: This study investigated the influence of four process parameters on the quality attributes of rAAV products. Regression models and a design space were established, and the predictive capability of the models was confirmed.

BIOTECHNOLOGY AND BIOENGINEERING (2023)

Article Biochemical Research Methods

Behavior of host-cell-protein-rich aggregates in antibody capture and polishing chromatography

Chase E. Herman, Lie Min, Leila H. Choe, Ronald W. Maurer, Xuankuo Xu, Sanchayita Ghose, Kelvin H. Lee, Abraham M. Lenhoff

Summary: Recent research has revealed that aggregates in mAb solutions may contain not only mAb oligomers but also hundreds of host-cell proteins (HCPs), which suggests a relationship between aggregate persistence and HCP clearance during downstream purification operations. This study found that the phenomenon is relevant to depth filtration, protein A chromatography, and flow-through anion-exchange (AEX) polishing. Confocal laser scanning microscopy showed that aggregates compete with mAb during protein A chromatography, and column chromatography confirmed the presence of high aggregate concentrations in the protein A elution tail. Similar observations were made in flow-through AEX chromatography, with aggregate retention depending on resin surface chemistry. The quantification of aggregate mass fraction may serve as a surrogate for informing early process development decisions regarding HCP clearance strategies.

JOURNAL OF CHROMATOGRAPHY A (2023)

Article Biochemical Research Methods

Prediction of CHO cell line stability using expression of DNA repair genes

Lauren T. Cordova, Hussain Dahodwala, Rebecca Cooley, Kelvin H. Lee

Summary: In this study, researchers evaluated the expression of five DNA repair genes in over 40 CHO cell lines and found a correlation between two genes and cell line stability. Additionally, they found a negative correlation between the expression levels of DNA repair genes and cell age.

BIOTECHNOLOGY JOURNAL (2023)

Review Biochemical Research Methods

Carbon recycling with synthetic CO2 fixation pathways

Pei-Ru Chen, Peng-Fei Xia

Summary: Carbon dioxide plays a crucial role in mitigating global climate change and supporting life on Earth. Synthetic biology and metabolic engineering offer a promising approach to enhance CO2 fixation by combining the advantages of autotrophic and heterotrophic organisms. This article reviews the current progress in constructing synthetic CO2 fixation pathways, discusses the underlying design principles and challenges, and provides insights into the future of carbon recycling through engineered synthetic carbon fixation pathways.

CURRENT OPINION IN BIOTECHNOLOGY (2024)